AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
DACLATASVIR DIHYDROCHLORIDE in Zimbabwe
1 product registered with MCAZ — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MYDEKLA 60 TABLET, COATED; ORAL | 2019/7.13/5764 | MYLAN LABORATORIES LIMITED | active | 7 May 2029 |
DACLATASVIR DIHYDROCHLORIDE — MCAZ Registration Details
MCAZ (Zimbabwe) has 1 registered product containing DACLATASVIR DIHYDROCHLORIDE, of which 1 is currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track DACLATASVIR DIHYDROCHLORIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.